Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2025-12-24 @ 2:44 PM
NCT ID:
NCT06373159
Eligibility Criteria:
Inclusion Criteria:
* Sepsis patient cohort
* Sepsis patients
* Age ≥18 years
* Subgroups:
* Sepsis with thrombocytopenia patient cohort
* Septic shock patient cohort
* Sepsis-associated DIC patient cohort
* DIC patients in sepsis patient cohort
* Subgroups:
* Organ failure: kidney (Serum creatinine (SCr) \< 1.2 mg/dl and ≥ 1.2 mg/dl)
* Organ failure: liver (bilirubin \< 1.2 mg/dl and ≥ 1.2 mg/dl)
* Organ failure: cardiovascular (with and without catecholamine or vasopressin)
* With low molecular weight (LMW) heparins, unfractionated heparins, and both
* With and without DIC treatment
* Priority 1\_Anticoagulants specifically used in Japan (recombinant antithrombin, recombinant thrombomodulin, human anti-thrombin III)
* Priority 1 + Priority 2\_Drugs for sepsis-associated DIC (LMW heparins, unfractionated heparins, protease inhibitors)
* Priority 1 + Priority 2 + Priority 3\_antibiotics (antifungals), and/or steroids
* Non-sepsis-associated DIC patient cohort
* Hematopoietic malignant tumor patients
* DIC patients
* Age ≥18 years
Exclusion Criteria:
* Sepsis patient cohort: None
* Sepsis-associated DIC patient cohort: None
* Non-sepsis-associated DIC patient cohort: Sepsis patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06373159
Study Brief:
Protocol Section:
NCT06373159